1887

Journal of General Virology header logo

Volume 93, Issue 7

Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa Free

Abstract

We investigated the molecular epidemiology and population dynamics of HCV infection among indigenes of two semi-isolated communities in North-Central Nigeria. Despite remoteness and isolation, ~15 % of the population had serological or molecular markers of hepatitis C virus (HCV) infection. Phylogenetic analysis of the NS5b sequences obtained from 60 HCV-infected residents showed that HCV variants belonged to genotype 1 ( = 51; 85 %) and genotype 2 ( = 9; 15 %). All sequences were unique and intermixed in the phylogenetic tree with HCV sequences from people infected from other West African countries. The high-throughput 454 pyrosequencing of the HCV hypervariable region 1 and an empirical threshold error correction algorithm were used to evaluate intra-host heterogeneity of HCV strains of genotype 1 ( = 43) and genotype 2 ( = 6) from residents of the communities. Analysis revealed a rare detectable intermixing of HCV intra-host variants among residents. Identification of genetically close HCV variants among all known groups of relatives suggests a common intra-familial HCV transmission in the communities. Applying Bayesian coalescent analysis to the NS5b sequences, the most recent common ancestors for genotype 1 and 2 variants were estimated to have existed 675 and 286 years ago, respectively. Bayesian skyline plots suggest that HCV lineages of both genotypes identified in the Nigerian communities experienced epidemic growth for 200–300 years until the mid-20th century. The data suggest a massive introduction of numerous HCV variants to the communities during the 20th century in the background of a dynamic evolutionary history of the hepatitis C epidemic in Nigeria over the past three centuries.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.042184-0
2012-07-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/7/1410.html?itemId=/content/journal/jgv/10.1099/vir.0.042184-0&mimeType=html&fmt=ahah

References

  1. Adewole O. O., Anteyi E., Ajuwon Z., Wada I., Elegba F., Ahmed P., Betiku Y., Okpe A., Eze S. other authors 2009; Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries 3:369–375 [View Article][PubMed]
     [Google Scholar]
  2. Agwale S. M., Tanimoto L., Womack C., Odama L., Leung K., Duey D., Negedu-Momoh R., Audu I., Mohammed S. B. other authors 2004; Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 31:Suppl. 1S3–S6 [View Article][PubMed]
     [Google Scholar]
  3. Alter M. J., Kruszon-Moran D., Nainan O. V., McQuillan G. M., Gao F., Moyer L. A., Kaslow R. A., Margolis H. S. 1999; The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341:556–562 [View Article][PubMed]
     [Google Scholar]
  4. Balogun T. M., Emmanuel S., Wright K. O. 2010; Hepatitis C virus co infection in HIV positive patients. Nig Q J Hosp Med 20:117–120[PubMed]
     [Google Scholar]
  5. Bracho M. A., Carrillo-Cruz F. Y., Ortega E., Moya A., Gonzalez-Candelas F. 2006; A new subtype of hepatitis C virus genotype 1: complete genome and phylogenetic relationships of an Equatorial Guinea isolate. J Gen Virol 87:1697–1702 [CrossRef]
     [Google Scholar]
  6. Bekondi C., Mobima T., Ouavènè J. O., Koffi B., Konamna X., Béré A., Le Faou A. 2010; [Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: clinical, biological characteristics and virological aspects of patients]. Pathol Biol (Paris) 58:152–155 [View Article][PubMed]
     [Google Scholar]
  7. Candotti D., Temple J., Sarkodie F., Allain J. P. 2003; Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 77:7914–7923 [View Article][PubMed]
     [Google Scholar]
  8. Drummond A. J., Rambaut A. 2007; beast: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214 [View Article][PubMed]
     [Google Scholar]
  9. EASL 1999; EASL International Consensus Conference on hepatitis C. Paris, 26–27 February 1999. Consensus statement. J Hepatol 31:Suppl. 13–8 [View Article][PubMed]
     [Google Scholar]
  10. Excoffier L., Laval G., Schneider S. 2005; arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47–50[PubMed]
     [Google Scholar]
  11. Ferraro D., Genovese D., Argentini C., Giordano V., Pizzillo P., Stroffolini T., Craxì A., Rapicetta M., Di Stefano R. 2008; Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: the Camporeale model. J Med Virol 80:1723–1731 [View Article][PubMed]
     [Google Scholar]
  12. Forbi J. C., Vaughan G., Purdy M. A., Campo D. S., Xia G. L., Ganova-Raeva L. M., Ramachandran S., Thai H., Khudyakov Y. E. 2010; Epidemic history and evolutionary dynamics of hepatitis B virus infection in two remote communities in rural Nigeria. PLoS ONE 5:e11615 [View Article][PubMed]
     [Google Scholar]
  13. Frank C., Mohamed M. K., Strickland G. T., Lavanchy D., Arthur R. R., Magder L. S., El Khoby T., Abdel-Wahab Y., Aly Ohn E. S. other authors 2000; The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887–891 [View Article][PubMed]
     [Google Scholar]
  14. Hnatyszyn H. J. 2005; Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 10:1–11[PubMed]
     [Google Scholar]
  15. Itskowitz M. S. 2007; Hepatitis C: epidemiology, diagnosis, and management. Compr Ther 33:87–93 [View Article][PubMed]
     [Google Scholar]
  16. Jeannel D., Fretz C., Traore Y., Kohdjo N., Bigot A., Pê Gamy E., Jourdan G., Kourouma K., Maertens G. other authors 1998; Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 55:92–97 [View Article][PubMed]
     [Google Scholar]
  17. Lampe E., Espirito-Santo M. P., Martins R. M., Bello G. 2010; Epidemic history of Hepatitis C virus in Brazil. Infect Genet Evol 10:886–895 [View Article][PubMed]
     [Google Scholar]
  18. Laraba A., Wadzali G., Sunday B., Abdulfatai O., Fatai S. 2010; Hepatitis C virus infection in Nigerians with chronic liver disease. . The Internet Journal of Gastroenterology 9:
     [Google Scholar]
  19. Lindenbach B. D., Rice C. M. 2005; Unravelling hepatitis C virus replication from genome to function. Nature 436:933–938 [View Article][PubMed]
     [Google Scholar]
  20. Magiorkinis G., Magiorkinis E., Paraskevis D., Ho S. Y., Shapiro B., Pybus O. G., Allain J. P., Hatzakis A. 2009; The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6:e1000198 [View Article][PubMed]
     [Google Scholar]
  21. Markov P. V., Pepin J., Frost E., Deslandes S., Labbé A. C., Pybus O. G. 2009; Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. J Gen Virol 90:2086–2096 [View Article][PubMed]
     [Google Scholar]
  22. Mellor J., Holmes E. C., Jarvis L. M., Yap P. L., Simmonds P. The International HCV Collaborative Study Group 1995; Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76:2493–2507 [View Article][PubMed]
     [Google Scholar]
  23. Millar J. D., Foege W. H. 1969; Status of eradication of smallpox (and control of measles) in West and Central Africa. J Infect Dis 120:725–732 [View Article][PubMed]
     [Google Scholar]
  24. Mustapha S. K., Bolori M. T., Ajayi N. A., Nggada H. A., Pindiga U. H., Gashau W., Khalil M. I. A. 2007; Hepatitis C virus antibodies in Nigerians with hepatocellular carcinoma. . The Internet Journal of Oncology 4:
     [Google Scholar]
  25. Nagalo M. B., Sanou M., Bisseye C., Kaboré M. I., Nebie Y. K., Kienou K., Kiba A., Dahourou H., Ouattara S. other authors 2011; Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 4:1–6[PubMed]
     [Google Scholar]
  26. Nakano T., Lau G. M., Lau G. M., Sugiyama M., Mizokami M. 2012; An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 32:339–345 [View Article][PubMed]
     [Google Scholar]
  27. Ndjomou J., Pybus O. G., Matz B. 2003; Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol 84:2333–2341 [View Article][PubMed]
     [Google Scholar]
  28. Ndong-Atome G. R., Njouom R., Padilla C., Bisvigou U., Makuwa M., Kazanji M. 2009; Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect. J Clin Virol 45:349–353 [View Article][PubMed]
     [Google Scholar]
  29. Nei M. 1987 Molecular Evolutionary Genetics New York: Columbia University Press;
     [Google Scholar]
  30. Newton M. A., Raftery A. E., Davison A. C., Bacha M., Celeux G., Carlin B. P., Clifford P., Lu C., Sherman M. other authors 1994; Approximate Bayesian-inference with the weighted likelihood bootstrap. J Roy Stat Soc B Met 56:3–48
     [Google Scholar]
  31. Njouom R., Pasquier C., Ayouba A., Gessain A., Froment A., Mfoupouendoun J., Pouillot R., Dubois M., Sandres-Sauné K. other authors 2003; High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71:219–225 [View Article][PubMed]
     [Google Scholar]
  32. Njouom R., Pasquier C., Ayouba A., Tejiokem M. C., Vessiere A., Mfoupouendoun J., Tene G., Eteki N., Lobe M. M., Izopet J. other authors 2005; Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study.. Am J Trop Med Hyg 73:460–466
     [Google Scholar]
  33. Njouom R., Nerrienet E., Dubois M., Lachenal G., Rousset D., Vessière A., Ayouba A., Pasquier C., Pouillot R. 2007; The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol 7:361–367 [View Article][PubMed]
     [Google Scholar]
  34. Njouom R., Frost E., Deslandes S., Mamadou-Yaya F., Labbe A. C., Pouillot R., Mbelesso P., Mbadingai S., Rousset D., Pepin J. 2009; Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 90:2452–2456
     [Google Scholar]
  35. Nwankiti O. O., Ndako J. A., Echeonwu G. O., Olabode A. O., Nwosuh C. I., Onovoh E. M., Okeke L. A., Akinola J. O., Duru B. N. other authors 2009; Hepatitis C virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J 6:110 [View Article][PubMed]
     [Google Scholar]
  36. Ocama P., Seremba E. 2011 Management of HIV and Hepatitis C Virus Infections in Resource-Limited Settings Curr Opin HIV AIDS; 6539–545
     [Google Scholar]
  37. Onakewhor J. U., Okonofua F. E. 2009; Seroprevalence of Hepatitis C viral antibodies in pregnancy in a tertiary health facility in Nigeria. Niger J Clin Pract 12:65–73[PubMed]
     [Google Scholar]
  38. Oni A. O., Harrison T. J. 1996; Genotypes of hepatitis C virus in Nigeria. J Med Virol 49:178–186 [View Article][PubMed]
     [Google Scholar]
  39. Pasquier C., Njouom R., Ayouba A., Dubois M., Sartre M. T., Vessière A., Timba I., Thonnon J., Izopet J., Nerrienet E. 2005; Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon . J Med Virol 77:390–398
     [Google Scholar]
  40. Pépin J., Labbé A. C. 2008; Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses. Trop Med Int Health 13:744–753 [View Article][PubMed]
     [Google Scholar]
  41. Pépin J., Lavoie M., Pybus O. G., Pouillot R., Foupouapouognigni Y., Rousset D., Labbé A. C., Njouom R. 2010; Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 51:768–776 [View Article][PubMed]
     [Google Scholar]
  42. Pouillot R., Lachenal G., Pybus O. G., Rousset D., Njouom R. 2008a; Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8:676–681 [View Article][PubMed]
     [Google Scholar]
  43. Pouillot R., Lachenal G., Pybus O. G., Rousset D., Njouom R. 2008b; Variable epidemic histories of hepatitis C virus genotype 2 infection in West Africa and Cameroon. Infect Genet Evol 8:676–681 [View Article][PubMed]
     [Google Scholar]
  44. Pybus O. G., Charleston M. A., Gupta S., Rambaut A., Holmes E. C., Harvey P. H. 2001; The epidemic behavior of the hepatitis C virus. Science 292:2323–2325 [View Article][PubMed]
     [Google Scholar]
  45. Ramachandran S., Xia G. L., Ganova-Raeva L. M., Nainan O. V., Khudyakov Y. 2008; End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 151:217–224 [View Article][PubMed]
     [Google Scholar]
  46. Ruggieri A., Argentini C., Kouruma F., Chionne P., D’Ugo E., Spada E., Dettori S., Sabbatani S., Rapicetta M. 1996; Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J Gen Virol 77:2073–2076 [View Article][PubMed]
     [Google Scholar]
  47. Shepard C. W., Finelli L., Alter M. J. 2005; Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558–567 [View Article][PubMed]
     [Google Scholar]
  48. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391–2399 [View Article][PubMed]
     [Google Scholar]
  49. Simmonds P., Bukh J., Combet C., Deléage G., Enomoto N., Feinstone S., Halfon P., Inchauspé G., Kuiken C. other authors 2005; Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962–973 [View Article][PubMed]
     [Google Scholar]
  50. Skums P., Dimitrova Z., Campo D. S., Vaughan G., Rossi L., Forbi J. C., Yokosawa J., Zelikovsky A., Khudyakov Y. 2012; Efficient error correction for deep sequencing of viral amplicons. BMC Bioinformatics In press
    [Google Scholar]
  51. Smith D. B., Pathirana S., Davidson F., Lawlor E., Power J., Yap P. L., Simmonds P. 1997; The origin of hepatitis C virus genotypes. J Gen Virol 78:321–328[PubMed]
     [Google Scholar]
  52. Stuyver L., Wyseur A., van Arnhem W., Lunel F., Laurent-Puig P., Pawlotsky J.-M., Kleter B., Bassit L., Nkengasong J., van Doorn L.-J. other authors 1995; Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 38:137–157 [CrossRef]
     [Google Scholar]
  53. Tamura K., Nei M., Kumar S. 2004; Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101:11030–11035 [View Article][PubMed]
     [Google Scholar]
  54. Tanaka Y., Hanada K., Mizokami M., Yeo A. E. T., Shih J. W. K., Gojobori T., Alter H. J. 2002; A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99:15584–15589 [View Article][PubMed]
     [Google Scholar]
  55. Tscherne D. M., Evans M. J., von Hahn T., Jones C. T., Stamataki Z., McKeating J. A., Lindenbach B. D., Rice C. M. 2007; Superinfection exclusion in cells infected with hepatitis C virus. J Virol 81:3693–3703 [View Article][PubMed]
     [Google Scholar]
  56. Viazov S., Widell A., Nordenfelt E. 2000; Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 28:21–25 [View Article][PubMed]
     [Google Scholar]
  57. Viazov S., Ross S. S., Kyuregyan K. K., Timm J., Neumann-Haefelin C., Isaeva O. V., Popova O. E., Dmitriev P. N., El Sharkawi F. other authors 2010; Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol 82:232–238 [View Article][PubMed]
     [Google Scholar]
  58. Wansbrough-Jones M. H., Frimpong E., Cant B., Harris K., Evans M. R., Teo C. G. 1998; Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans R Soc Trop Med Hyg 92:496–499 [View Article][PubMed]
     [Google Scholar]
  59. WHO 1999; Hepatitis C: Weekly Epidemiological Record. No. 49, 10 December 1999, World Health Organisation Fact sheet no. 164.
  60. Zeuzem S. 2004; Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?. Ann Intern Med 140:370–381[PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.042184-0
Loading
Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa
J. Gen. Virol. 93, 1410 (2012); https://doi.org/10.1099/vir.0.042184-0
/content/journal/jgv/10.1099/vir.0.042184-0
/content/journal/jgv/10.1099/vir.0.042184-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error